Ledger.Open graph →
SEC Form D · filed April 13, 2021

MediSix Therapeutics, Inc

Offering
$22.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Michael D. Carusi · BOSTON, MADirectorWilliam A. Harrington · BOSTON, MADirectorGeorge A. Poste · BOSTON, MADirectorAndrew R. Bruce · BOSTON, MAExec · DirectorNadir Noorani · Matthews, NCDirectorBrian E. Handly · Raleigh, NCDirectorBinayak R. Mishra · New York, NYExec · DirectorAnup Desai · Matthews, NCDirectorKenneth D. Noonan · Singapore, U0DirectorDouglas R. Jamieson · Rye, NYDirectorWan Li Zhu · Roxbury, MADirectorJit Kee Chin · Roxbury, MADirectorPuneet Mahajan · Roxbury, MAExec · DirectorKenneth D. Noonan · Singapore, U0Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗